checkAd

DGAP-News B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results

Nachrichtenquelle: EQS Group AG
26.02.2021, 07:30  |  149   |   |   

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Quarter Results
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results

26.02.2021 / 07:30
The issuer is solely responsible for the content of this announcement.


Zwingenberg, Germany, 26. February 2021

BRAIN AG Q1 '20/'21 Results

  • Strong performance of Biocatalysts
  • BioScience high comparison base and lower milestones
  • Solid Cash Position


Today, B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG, ISIN DE0005203947 / WKN 520394) published its results for the first quarter of the financial year 2020/21. Group revenues in the reporting period from October 1, 2020 to December 31, 2020 decreased by 21.7 % to € 8.1 million from € 10.3 million. This is mainly attributable to the BioScience segment which has a highly volatile revenue recognition quarter on quarter due to timing effects and milestone payments. The Group adjusted EBITDA decreased to € -1.4 million from € -0.2 million in the first three months of the 2020/21 financial year.

In the same period, the BRAIN Group generated a total operating performance of € 8.5 million compared to € 10.4 million in the same period of the previous year. The total operating performance was thus 18.3 % lower than in the previous year. The cash position at the end of the quarter amounted to a solid € 16.1 million.

Business Development by segment

The BioScience segment, which includes the R&D business with industrial partners, achieved revenues of € 2.0 million in the first quarter of 2020/21, minus 50% from the prior-year quarter. The BioScience segment is very volatile on a quarter on quarter basis due to timing effects of contracts and larger milestone payments. BRAIN expects an improvement of the divisional sales performance during the course of the year. Adjusted EBITDA of this segment decreased to € -1.7 million from € -0.6 million, mainly due to lower revenues.

Seite 1 von 5
B.R.A.I.N. Biotechnology Research and Information Network Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

DGAP-News B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Quarter Results B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results 26.02.2021 / 07:30 The issuer is solely responsible …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel